Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 1;2012(12):2135-2140.
doi: 10.1002/ejic.201101166. Epub 2012 Feb 8.

Physical Properties of Eu(2+)-Containing Cryptates as Contrast Agents for Ultra-High Field Magnetic Resonance Imaging

Affiliations

Physical Properties of Eu(2+)-Containing Cryptates as Contrast Agents for Ultra-High Field Magnetic Resonance Imaging

Joel Garcia et al. Eur J Inorg Chem. .

Abstract

The kinetic stabilities and relaxivities of a series of Eu(2+)-containing cryptates have been investigated. Transmetallation studies that monitored the change in the longitudinal relaxation rate of water protons in the presence of Ca(2+), Mg(2+), and Zn(2+) demonstrated that cryptate structure influences stability, and two of the cryptates studied were inert to transmetallation in the presence of these endogenous ions. The efficacy of these cryptates was determined at different magnetic field strengths, temperatures, and pH values. Cryptate relaxivity was found to be higher at ultra-high field strengths (7 and 9.4 T) relative to clinically relevant field strengths (1.4 and 3 T), but the efficiency of these cryptates decreased as temperature increased. In addition, variation in pH did not yield significant changes in the efficacy of the cryptates. These studies establish a foundation of important properties that are necessary to develop effective positive contrast agents for magnetic resonance imaging from Eu(2+)-containing cryptates.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evolution of R1p(t)/R1p(t=0) versus time for the Eu2+-containing cryptates Eu–1 (◇) and Eu–2 (□) (2.5 mM) in the presence of Ca2+ (2.5 mM). The value 0.8 on the y-axis is the threshold for the kinetic index. Error bars represent standard error of the mean.
Figure 2
Figure 2
Evolution of R1p(t)/R1p(t=0) versus time for the Eu2+-containing cryptates Eu–1 (◇) and Eu–2 (□) (2.5 mM) in the presence of Mg2+ (2.5 mM). The value 0.8 on the y-axis is the threshold for the kinetic index. Error bars represent standard error of the mean.
Figure 3
Figure 3
Evolution of R1p(t)/R1p(t=0) versus time for the Eu2+-containing cryptates Eu–1 (◇) and Eu–2 (□) (2.5 mM) in the presence of Zn2+ (2.5 mM). The value 0.8 on the y-axis is the threshold for the kinetic index. Error bars represent standard error of the mean.
Figure 4
Figure 4
Contributing resonance structures of cryptands 3 and 4.
Figure 5
Figure 5
Proton longitudinal relaxivity (T = 20 °C, pH = 7.4) of GdDOTA (○) and Eu2+-containing cryptates Eu–1 (◇) and Eu–2 (□) as a function of magnetic field strength. Values at 3, 7, and 11.7 T are from reference . Error bars represent standard error of the mean.
Figure 6
Figure 6
Proton longitudinal relaxivity (T = 37 °C, pH = 7.4) of GdDOTA (○) and Eu2+-containing cryptates Eu–1 (◇) and Eu–2 (□) as a function of magnetic field strength. Values at 1.4 and 11.7 T are from reference . Error bars represent standard error of the mean.
Figure 7
Figure 7
Proton longitudinal relaxivity (9.4 T and pH = 7.4) of Eu2+-containing cryptates Eu–1 (□) and Eu–2 (cir;) as a function of temperature. Error bars represent standard error of the mean.
Figure 8
Figure 8
Proton longitudinal relaxivity (11.7 T, pH = 7.4) of Eu2+-containing cryptates Eu–1 (□) and Eu–2 (cir;) as a function of temperature. Error bars represent standard error of the mean.
Figure 9
Figure 9
Longitudinal relaxivity at 1.4 T at 37 °C (Eu–1 (■) and Eu–2 (●)) and 7 T at 19 °C (Eu–1 (□) and Eu–2 (cir;)) as a function of pH. Error bars represent standard error of the mean.
Scheme 1
Scheme 1
Structures of cryptands 14.
Scheme 2
Scheme 2
Synthetic route to cryptands 3 and 4.

References

    1. Caravan P, Farrar CT, Frullano L, Uppal R. Contrast Media Mol Imaging. 2009;4:89–100. - PMC - PubMed
    1. Burai L, Scopelliti R, Toth E. Chem Commun. 2002:2366–2367. - PubMed
    2. Toth E, Burai L, Merbach AE. Coord Chem Rev. 2001;216–217:363–382.
    3. Caravan P, Toth E, Rockenbauer A, Merbach AE. J Am Chem Soc. 1999;121:10403–10409.
    1. Garcia J, Neelavalli J, Haacke EM, Allen MJ. Chem Commun. 2011;47:12858–12860. - PMC - PubMed
    1. Yee EL, Gansow OA, Weaver MJ. J Am Chem Soc. 1980;102:2278–2285.
    1. Wolfson JM, Kearns DR. Biochemistry. 1975;14:1436–1444. - PubMed
    2. Ogawa Y, Suzuki S, Naito K, Saito M, Kamata E, Hirose A, Ono A, Kaneko T, Chiba M, Inaba Y, Kurokawa Y. J Environ Pathol Oncol. 1995;14:1–9. - PubMed

LinkOut - more resources